NCT01223131 - Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old. | Biotech Hunter

Enrollment

162

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG

Insulin glargine (HOE901)

"Pharmaceutical form:aqueous solution for injection~Route of administration: Subcutaneous"

DRUG

NPH insulin

"Pharmaceutical form:aqueous solution for injection~Route of administration: Subcutaneous"

Trial Locations (10)

Investigational Site Number 156006, Beijing

Investigational Site Number 156001, Beijing

Investigational Site Number 156007, Beijing

Investigational Site Number 156016, Shanghai

Investigational Site Number 156005, Shanghai

Investigational Site Number 156004, Hangzhou

Investigational Site Number 156009, Changsha

Investigational Site Number 156002, Wuhan

Investigational Site Number 156008, Guangzhou

Investigational Site Number 156019, Taiyuan